Risk Factors for Microscopic Colitis
1 other identifier
observational
346
1 country
1
Brief Summary
Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unknown. Understanding the etiology of microscopic colitis is an important step in developing logical interventions to decrease the burden from microscopic colitis. This research could provide critical insights into the etiology of this poorly studied condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2016
CompletedFirst Posted
Study publicly available on registry
March 4, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2020
CompletedFebruary 21, 2021
February 1, 2021
4.7 years
February 23, 2016
February 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Microscopic Colitis
Microscopic colitis defined by increased lymphocytes or collagen
Day 1
Study Arms (2)
Microscopic colitis cases
Patients found to have microscopic colitis based on colonic biopsies.
Controls
Patients who meet eligibility requirements but do not have microscopic colitis on biopsy.
Eligibility Criteria
Patients who undergo colonoscopy for diarrhea at the University of North Carolina
You may qualify if:
- Colonoscopy for diarrhea
You may not qualify if:
- Fewer than 4 loose bowel movements per day.
- Failure to visualize the entire colon to the cecum or preparation less than good or excellent.
- Age under 35 years. There will be no upper age limit.
- Inability to understand and cooperate with the interview.
- Indication for colonoscopy other than diarrhea.
- Prior history of inflammatory bowel disease (Crohn's disease or ulcerative colitis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27599-7555, United States
Biospecimen
40 ml of blood centrifuged and separated into plasma, buffy coat and red blood cells. A serum separator tube will be used to collect an additional 10 ml of blood for serum. During colonoscopy, four mucosal biopsies will be obtained from normal appearing mucosa in the ascending colon, transverse colon, and descending/sigmoid colon during the withdrawal phase of the exam from each patient (12 research biopsies). To improve orientation 2 biopsies from each segment will be flattened onto filter paper using a forceps and placed together into fixative. The remaining 2 biopsies from each area will be rinsed in sterile PBS to ensure there is no contamination with fecal bacteria prior to freezing in liquid nitrogen.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert S. Sandler, MD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2016
First Posted
March 4, 2016
Study Start
May 1, 2016
Primary Completion
December 24, 2020
Study Completion
December 24, 2020
Last Updated
February 21, 2021
Record last verified: 2021-02